The Best Science Demands the Best Reagents.

Current virology research is hindered by outdated and inaccurate methods for producing virus stocks—the foundation of biomedical research. Most available virus strains are created through serial passage in cultured cells, which introduces mutations that make them significantly different from natural viruses. This creates a critical problem: vaccines, therapeutics, and diagnostics designed for these lab-adapted strains often fail against real-world viruses.

At Advanced Virology, we’re changing that. By providing verified, high-fidelity virus stocks and derivative products, we enable researchers to develop more effective treatments, save time, and prevent wasted resources. Better reagents. Better science. Better outcomes.

Advanced Virology

Org chart

Teams

Offices